{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:20:21Z","timestamp":1788970821897,"version":"build-2803163510"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"\n Importance<\/jats:title>\n Patient and caregiver values and preferences should inform clinical management. An update to the American Academy of Allergy, Asthma &amp;amp; Immunology\/American College of Allergy, Asthma and Immunology\u2019s Joint Task Force on Practice Parameters guidelines on chronic urticaria (CU) plans to incorporate them; however, a systematic review of evidence on the values and preferences of patients with CU and their caregivers has not been previously available.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To synthesize patient and caregiver values and preferences regarding CU treatment options.<\/jats:p>\n <\/jats:sec>\n \n Evidence Review<\/jats:title>\n A systematic search was conducted of MEDLINE, Embase, PsycINFO, and CINAHL databases, from inception to May 15, 2025, for studies addressing patient and\/or caregiver values and preferences for CU management. Paired reviewers independently screened studies, extracted data, and assessed risk of bias. Thematic and inductive content analysis was used to qualitatively synthesize findings and certainty of evidence was rated per the Grading of Recommendations Assessment, Development and Evaluation\u2212Confidence in the Evidence from Reviews of Qualitative Research approach.<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n The search resulted in 18 studies addressing the values and preferences among 28\u202f497 participants. Moderate certainty evidence showed that patients were likely to place a high value on rapid improvement (eg, 2 days to 2 weeks) of disease signs and symptoms, long-term effectiveness, and treatments that were easy to prepare, use, and self-manage\u2014oral or topical treatments were favored over injections, with the least favored being infusions. Low certainty evidence suggested that patients accepted minor feasibility burdens for rapid and sustained symptom relief but prioritized safety and tolerability as the risk or severity of adverse effects (eg, kidney injury, vomiting) increased.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This systematic review suggests that patients with CU place high value on immediate and sustained hive, itch, and swelling relief, particularly long-term symptom-free periods, but may shift to prioritizing avoiding harms and burdens as the risk and severity of adverse effects increases. These findings may serve as a resource to improve the trustworthiness of recommendations and inform future CU management and research.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.3663","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:00:53Z","timestamp":1759935653000},"page":"1264","source":"Crossref","is-referenced-by-count":5,"title":["Patient Values and Preferences in Chronic Urticaria Treatment"],"prefix":"10.1001","volume":"161","author":[{"given":"Xiajing","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Mubasher","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandro W. L.","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Oykhman","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Brignardello-Petersen","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Fog","family":"Heen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Allergy and Immunology, The University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane R.","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health & Sciences University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Oliver","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Allergy, Southern California Permanente Medical Group, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Allergy, Immunology and Dermatology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer K.","family":"Mathur","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily F.","family":"Cole","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chan","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Southlake Regional Health Centre, Newmarket, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Trayes","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Runyon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Allergy and Immunology, The University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tran","sequence":"additional","affiliation":[{"name":"University of Arizona College of Medicine, Phoenix Children\u2019s Hospital, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Asiniwasis","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Saskatchewan, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Allergy & Asthma Network, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Eftekhari","sequence":"additional","affiliation":[{"name":"Asthma and Allergy Foundation of America, Arlington, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[{"name":"Global Allergy & Airways Patient Platform, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Tattrie","sequence":"additional","affiliation":[{"name":"Port Alberni, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"The Research Institute of St Joe\u2019s Hamilton, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"drv250004r1","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.jaip.2023.06.033","article-title":"Chronic urticaria and angioedema: masqueraders and misdiagnoses.","volume":"11","author":"Bernstein","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"drv250004r2","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update.","volume":"133","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"drv250004r3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1056\/NEJMra2120166","article-title":"Chronic Urticaria.","volume":"387","author":"Lang","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"drv250004r4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jaci.2022.10.004","article-title":"Chronic spontaneous urticaria guidelines: what is new?","volume":"150","author":"Zuberbier","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"drv250004r5","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.jaip.2020.03.030","article-title":"Urticaria and angioedema across the ages.","volume":"8","author":"Saini","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"drv250004r6","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE.","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"drv250004r7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.jaip.2022.06.017","article-title":"Trustworthy patient-centered guidelines: insights from atopic dermatitis and a proposal for the future.","volume":"10","author":"Agarwal","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"drv250004r8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jamadermatol.2022.6045","article-title":"Values and preferences of patients and caregivers regarding treatment of atopic dermatitis (eczema): a systematic review.","volume":"159","author":"Maleki-Yazdi","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv250004r9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","article-title":"Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.","volume":"15","author":"Zhang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"drv250004r10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"drv250004r11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.anai.2024.06.003","article-title":"Topical corticosteroids for hives and itch (urticaria): systematic review and Bayesian meta-analysis of randomized trials.","volume":"133","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"drv250004r12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaci.2024.05.026","article-title":"Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: systematic review and meta-analysis of randomized clinical trials.","volume":"154","author":"Rayner","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"drv250004r13","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jaip.2024.04.016","article-title":"Efficacy and safety of systemic corticosteroids for urticaria: a systematic review and meta-analysis of randomized clinical trials.","volume":"12","author":"Chu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"71","key":"drv250004r14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"drv250004r16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","article-title":"Extracting data from figures with software was faster, with higher interrater reliability than manual extraction.","volume":"74","author":"Jelicic Kadic","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"drv250004r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050831","article-title":"Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review.","volume":"11","author":"Zeng","year":"2021","journal-title":"BMJ Open"},{"key":"drv250004r18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijnurstu.2016.03.010","article-title":"How do patients\u2019 values influence heart failure self-care decision-making?: A mixed-methods systematic review.","volume":"59","author":"Karimi","year":"2016","journal-title":"Int J Nurs Stud"},{"issue":"10","key":"drv250004r19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.7326\/M19-1326","article-title":"Health-related values and preferences regarding meat consumption: a mixed-methods systematic review.","volume":"171","author":"Valli","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"drv250004r20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11135-017-0533-4","article-title":"A classification of response scale characteristics that affect data quality: a literature review.","volume":"52","author":"DeCastellarnau","year":"2018","journal-title":"Qual Quant"},{"issue":"16","key":"drv250004r21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/heartjnl-2020-318334","article-title":"Patient values and preferences on valve replacement for aortic stenosis: a systematic review.","volume":"107","author":"Heen","year":"2021","journal-title":"Heart"},{"key":"drv250004r22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jclinepi.2020.10.002","article-title":"A framework for practical issues was developed to inform shared decision-making tools and clinical guidelines.","volume":"129","author":"Heen","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"drv250004r23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00403-021-02321-z","article-title":"Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study.","volume":"315","author":"de Wijs","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"drv250004r24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews.","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"drv250004r25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041229","article-title":"Parents and GPs\u2019 understandings and beliefs about food allergy testing in children with eczema: qualitative interview study within the Trial of Eczema allergy Screening Tests (TEST) feasibility trial.","volume":"10","author":"Clement","year":"2020","journal-title":"BMJ Open"},{"key":"drv250004r26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","article-title":"GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness.","volume":"111","author":"Zhang","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"drv250004r27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13012-017-0694-5","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 7: understanding the potential impacts of dissemination bias.","volume":"13","author":"Booth","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13012-017-0691-8","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 4: how to assess coherence.","volume":"13","author":"Colvin","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13012-017-0692-7","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 5: how to assess adequacy of data.","volume":"13","author":"Glenton","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13012-017-0689-2","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 2: how to make an overall CERQual assessment of confidence and create a summary of qualitative findings table.","volume":"13","author":"Lewin","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-017-0688-3","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series.","volume":"13","author":"Lewin","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13012-017-0690-9","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 3: how to assess methodological limitations.","volume":"13","author":"Munthe-Kaas","year":"2018","journal-title":"Implement Sci"},{"key":"drv250004r33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13012-017-0693-6","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 6: how to assess relevance of the data.","volume":"13","author":"Noyes","year":"2018","journal-title":"Implement Sci"},{"issue":"4","key":"drv250004r34","first-page":"384","article-title":"Do traditional beliefs about urticaria affect patient satisfaction in South India? \u2013 A knowledge, attitude and practices survey.","volume":"29","author":"Sahu","year":"2019","journal-title":"J Pak Assoc Dermatol"},{"issue":"2","key":"drv250004r35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/09546634.2018.1476651","article-title":"Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria.","volume":"30","author":"Akdogan","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"drv250004r36","doi-asserted-by":"publisher","first-page":"AB89","DOI":"10.1016\/j.jaci.2023.11.298","article-title":"Quantifying patient preferences for treatments for refractory chronic spontaneous urticaria.","volume":"153","author":"Babalola","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"drv250004r37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4077\/CJP.2010.AMK007","article-title":"An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients.","volume":"53","author":"Fang","year":"2010","journal-title":"Chin J Physiol"},{"issue":"10","key":"drv250004r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100587","article-title":"Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective.","volume":"14","author":"King","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"4","key":"drv250004r39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14203","article-title":"ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.","volume":"174","author":"Maurer","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"drv250004r40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1398-9995.2008.01853.x","article-title":"Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation.","volume":"64","author":"Maurer","year":"2009","journal-title":"Allergy"},{"issue":"6","key":"drv250004r41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/ddg.14415","article-title":"Treatment satisfaction in chronic urticaria during guideline-based therapy.","volume":"19","author":"R\u00f6nsch","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"drv250004r42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1684\/ejd.2020.3763","article-title":"Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria.","volume":"30","author":"Sommer","year":"2020","journal-title":"Eur J Dermatol"},{"issue":"3","key":"drv250004r43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/11314870-000000000-00000","article-title":"Use of, satisfaction with, and willingness to switch prescription and over-the-counter treatments for chronic urticaria: an online survey.","volume":"2","author":"Stull","year":"2009","journal-title":"Patient"},{"issue":"3","key":"drv250004r44","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13555-021-00537-5","article-title":"Patients with Chronic Urticaria Remain Largely Undertreated: results from the DERMLINE Online Survey.","volume":"11","author":"Wagner","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"drv250004r45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/13548506.2022.2029914","article-title":"Psychological well-being, quality of life and patient satisfaction among adults with chronic spontaneous urticaria in a multi-ethnic Asian population.","volume":"28","author":"Yong","year":"2023","journal-title":"Psychol Health Med"},{"key":"drv250004r46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.32932\/rpia.2023.04.109","article-title":"Autoadministra\u00e7\u00e3o de omalizumab na urtic\u00e1ria cr\u00f3nica espont\u00e2nea \u2013 Estudo observacional num centro UCARE.","author":"Bernardino","year":"2023","journal-title":"Rev Port Imunoalergol"},{"issue":"2","key":"drv250004r47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40271-024-00725-3","article-title":"Assessing preferences of patients with chronic spontaneous urticaria for injectable treatment profiles.","volume":"18","author":"Gim\u00e9nez-Arnau","year":"2025","journal-title":"Patient"},{"issue":"4","key":"drv250004r48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/09546634.2019.1591580","article-title":"Patient experiences of using Chinese herbal medicine for psoriasis vulgaris and chronic urticaria: a qualitative study.","volume":"31","author":"Coyle","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"drv250004r49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/ejhpharm-2019-001914","article-title":"Multicentre experience of home omalizumab treatment for chronic spontaneous urticaria.","volume":"27","author":"Denman","year":"2020","journal-title":"Eur J Hosp Pharm"},{"issue":"12","key":"drv250004r50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2340\/00015555-3282","article-title":"Perspectives on living with chronic spontaneous urticaria: from onset through diagnosis and disease management in the US.","volume":"99","author":"Goldstein","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"drv250004r51","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.1016\/j.jval.2021.11.1193","article-title":"Understanding the impact of chronic spontaneous urticaria (CSU) and what is most important to patients 2014; results from qualitative patient interviews.","volume":"25","author":"Maurer","year":"2022","journal-title":"Value Health"},{"key":"drv250004r52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach.","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"issue":"3","key":"drv250004r53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13555-025-01348-8","article-title":"Urticaria voices: real-world experience of patients living with chronic spontaneous urticaria.","volume":"15","author":"Weller","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"drv250004r54","doi-asserted-by":"publisher","first-page":"AB138","DOI":"10.1016\/j.jaci.2022.12.430","article-title":"Online education with the patient voice highlights continuous gaps in care and needs for therapeutic options for chronic spontaneous urticaria (CSU) management.","volume":"151","author":"Drexel","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"drv250004r55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12325-023-02724-6","article-title":"A Patient charter for chronic urticaria.","volume":"41","author":"Maurer","year":"2024","journal-title":"Adv Ther"},{"issue":"3","key":"drv250004r56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"drv250004r57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.anai.2012.11.022","article-title":"Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.","volume":"110","author":"Song","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"drv250004r58","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1159\/000530494","article-title":"Long-term omalizumab in elderly patients with chronic urticaria: is it a safe therapy?","volume":"184","author":"Narv\u00e1ez-Fern\u00e1ndez","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"drv250004r59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.06.004","article-title":"Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis.","author":"Chu","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"drv250004r60","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jamadermatol.2024.2056","article-title":"Multinational drug survival study of omalizumab in patients with chronic urticaria and potential predictors for discontinuation.","volume":"160","author":"Soegiharto","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv250004r61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12911-025-02945-5","article-title":"Practical applications of methods to incorporate patient preferences into medical decision models: a scoping review.","volume":"25","author":"Fusiak","year":"2025","journal-title":"BMC Med Inform Decis Mak"},{"key":"drv250004r15","unstructured":"Mark? M, Baurzhan? M, Tobias? W, Alexander? W, Bas? VS. Badshah400. markummitchell\/engauge-digitizer: Nonrelease.? Zenodo; 2020."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2839732\/jamadermatology_chu_2025_rv_250004_1765313907.75486.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:00:43Z","timestamp":1765987243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2839732"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.3663","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}